Benzonatate NDC 68788-8336

Product information

Brand name (proprietary)

Benzonatate

Generic name (nonproprietary)

benzonatate

Active ingredients

Benzonatate — 200 mg/1

Dosage form

Capsule

Route

Oral

Labeler

Preferred Pharmaceuticals, Inc.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 211518

Marketing start

Apr 6, 2023

Listing expires

Dec 31, 2027

Other FDA classes

Decreased Tracheobronchial Stretch Receptor Activity (Physiologic effect)

Identifiers

Product ID 68788-8336_cb8266bf-7543-4ac4-aaea-086a497079f9SPL ID cb8266bf-7543-4ac4-aaea-086a497079f9SPL set ID fe5e8a94-ac75-4657-a45a-1fe94dbe0d43RxCUI 283417UNII 5P4DHS6ENR

Pharmacologic class

Non-narcotic Antitussive

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468788833601 followed by a unit qualifier and the quantity Copy

Package 68788-8336-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 211518

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.